See also:

1. European reference network for rare neuromuscular diseases: EURO-NMD EURO-NMD is a European reference network for the thematic grouping of rare neuromuscular diseases (NMDs), a broad group of related disorders that represent a major cause of mortality and lifelong disability in children and adults. NMDs are caused by acquired or genetic defects of motorneurons, peripheral nerves, neuromuscular junctions or...
2. MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide NMDs represent a major cause of mortality and morbidity in children and adults. NMDs collectively affect an estimated 500,000 EU citizens and result in significant costs for families and healthcare systems. Many institutions and organisations, including the MRC Centre for Neuromuscular Diseases, have reduced the gap between science discoveries and...
3. Co-morbidities in a cohort of adult Duchenne muscular dystrophy patients attending a Neuromuscular Complex Care Centre – an observational study Current guidelines for DMD care include early treatment with glucocorticoids, as well as cardiorespiratory, orthopaedic and rehabilitative intervention. Improvement in standards of care has altered the natural history of the condition, leading to increased survival of a population of patients with special needs, from the late teens to the third...
4. Axial myopathy in patients with neuromuscular diseases Muscle atrophy and weakness of upper and lower extremity muscles are well characterized in neuromuscular diseases, but involvement of the axial muscles is poorly understood. Since the axial musculature stabilizes and moves the trunk and provides stability for movement of the extremities, knowledge about the axial musculature in patients with...